These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 7504171

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY, Waksman G.
    J Mol Biol; 2002 Feb 15; 316(2):291-304. PubMed ID: 11851339
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal.
    Ladbury JE, Lemmon MA, Zhou M, Green J, Botfield MC, Schlessinger J.
    Proc Natl Acad Sci U S A; 1995 Apr 11; 92(8):3199-203. PubMed ID: 7536927
    [Abstract] [Full Text] [Related]

  • 5. Selective binding of activated pp60c-src by an immobilized synthetic phosphopeptide modeled on the carboxyl terminus of pp60c-src.
    Roussel RR, Brodeur SR, Shalloway D, Laudano AP.
    Proc Natl Acad Sci U S A; 1991 Dec 01; 88(23):10696-700. PubMed ID: 1720546
    [Abstract] [Full Text] [Related]

  • 6. Identification of residues in GTPase-activating protein Src homology 2 domains that control binding to tyrosine phosphorylated growth factor receptors and p62.
    Marengere LE, Pawson T.
    J Biol Chem; 1992 Nov 15; 267(32):22779-86. PubMed ID: 1385407
    [Abstract] [Full Text] [Related]

  • 7. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
    van der Geer P, Wiley S, Lai VK, Olivier JP, Gish GD, Stephens R, Kaplan D, Shoelson S, Pawson T.
    Curr Biol; 1995 Apr 01; 5(4):404-12. PubMed ID: 7542991
    [Abstract] [Full Text] [Related]

  • 8. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM, Mitaxov V, Waksman G.
    J Mol Biol; 1999 Nov 05; 293(4):971-85. PubMed ID: 10543978
    [Abstract] [Full Text] [Related]

  • 9. SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides.
    Case RD, Piccione E, Wolf G, Benett AM, Lechleider RJ, Neel BG, Shoelson SE.
    J Biol Chem; 1994 Apr 08; 269(14):10467-74. PubMed ID: 8144631
    [Abstract] [Full Text] [Related]

  • 10. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G, Davis B, Kristensen SM, Sankar A, Linacre J, Stein RC, Panayotou G, Waterfield MD, Driscoll PC.
    J Mol Biol; 1998 Feb 20; 276(2):461-78. PubMed ID: 9512716
    [Abstract] [Full Text] [Related]

  • 11. Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor.
    Nishimura R, Li W, Kashishian A, Mondino A, Zhou M, Cooper J, Schlessinger J.
    Mol Cell Biol; 1993 Nov 20; 13(11):6889-96. PubMed ID: 7692233
    [Abstract] [Full Text] [Related]

  • 12. Conformational basis for SH2-Tyr(P)527 binding in Src inactivation.
    Ayrapetov MK, Wang YH, Lin X, Gu X, Parang K, Sun G.
    J Biol Chem; 2006 Aug 18; 281(33):23776-84. PubMed ID: 16790421
    [Abstract] [Full Text] [Related]

  • 13. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.
    Karlsson T, Songyang Z, Landgren E, Lavergne C, Di Fiore PP, Anafi M, Pawson T, Cantley LC, Claesson-Welsh L, Welsh M.
    Oncogene; 1995 Apr 20; 10(8):1475-83. PubMed ID: 7537362
    [Abstract] [Full Text] [Related]

  • 14. Involvement of pp60c-src with two major signaling pathways in human breast cancer.
    Luttrell DK, Lee A, Lansing TJ, Crosby RM, Jung KD, Willard D, Luther M, Rodriguez M, Berman J, Gilmer TM.
    Proc Natl Acad Sci U S A; 1994 Jan 04; 91(1):83-7. PubMed ID: 7506422
    [Abstract] [Full Text] [Related]

  • 15. Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase.
    Grucza RA, Bradshaw JM, Mitaxov V, Waksman G.
    Biochemistry; 2000 Aug 22; 39(33):10072-81. PubMed ID: 10955995
    [Abstract] [Full Text] [Related]

  • 16. Kinetics of p56lck and p60src Src homology 2 domain binding to tyrosine-phosphorylated peptides determined by a competition assay or surface plasmon resonance.
    Payne G, Shoelson SE, Gish GD, Pawson T, Walsh CT.
    Proc Natl Acad Sci U S A; 1993 Jun 01; 90(11):4902-6. PubMed ID: 7685110
    [Abstract] [Full Text] [Related]

  • 17. Calorimetric examination of high-affinity Src SH2 domain-tyrosyl phosphopeptide binding: dissection of the phosphopeptide sequence specificity and coupling energetics.
    Bradshaw JM, Waksman G.
    Biochemistry; 1999 Apr 20; 38(16):5147-54. PubMed ID: 10213620
    [Abstract] [Full Text] [Related]

  • 18. Sequence requirements for binding of Src family tyrosine kinases to activated growth factor receptors.
    Alonso G, Koegl M, Mazurenko N, Courtneidge SA.
    J Biol Chem; 1995 Apr 28; 270(17):9840-8. PubMed ID: 7730365
    [Abstract] [Full Text] [Related]

  • 19. Deletion of the SH3 domain of Src interferes with regulation by the phosphorylated carboxyl-terminal tyrosine.
    Okada M, Howell BW, Broome MA, Cooper JA.
    J Biol Chem; 1993 Aug 25; 268(24):18070-5. PubMed ID: 7688738
    [Abstract] [Full Text] [Related]

  • 20. Heteronuclear NMR studies of the combined Src homology domains 2 and 3 of pp60 c-Src: effects of phosphopeptide binding.
    Tessari M, Gentile LN, Taylor SJ, Shalloway DI, Nicholson LK, Vuister GW.
    Biochemistry; 1997 Nov 25; 36(47):14561-71. PubMed ID: 9398174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.